- Investing Ideas
- /
- South African Pharmaceuticals & Biotech Undervalued based on future growth
South African Pharmaceuticals & Biotech Undervalued based on future growth
Results
1
1 new
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
1 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
APN New | R170.00 | -2.2% | -16.5% | R75.5b | R221.50 | PE17.1x | E21.9% | 2.1% |
Page 1 of 1